ARTICLE | Clinical News
MenHibrix regulatory update
April 25, 2011 7:00 AM UTC
GlaxoSmithKline submitted a response to FDA's June complete response letter for a BLA for MenHibrix vaccine against Neisseria meningitides serogroups C and Y, and Haemophilus influenzae type b ( Hib)....